Events

Name: Updates from European Renal Association (ERA) Congress 2024 – Outcomes and Clinical Implications of GLP-1 RA in T2DM and CKD
Start: 2024-05-27T19:00:00+10:00
End: 2024-05-27T20:00:00+10:00

Updates from European Renal Association (ERA) Congress 2024 – Outcomes and Clinical Implications of GLP-1 RA in T2DM and CKD

Live Panel Discussion
The use of GLP-1 agonists are revolutionising the care of type 2 diabetes and chronic kidney disease. Join us on Monday, 27 May 2024 from 7:00 pm to 8:00 pm (AEST) as our panel of experts discuss the effects of GLP-1 agonists on renal outcomes.

We will be reviewing study results presented at the ERA Congress 2024 and their implications for clinical practice in Australia.

Expert Panel

Click here to view the event flyer.
Click here to register for the webinar.

Registration is free to attend.

For any further information please contact the ADS Secretariat via email to ads@diabetessociety.com.au

The ADS gratefully acknowledges the support from Novo Nordisk. This is an independent educational event and Novo Nordisk does not have an influence on the program, speakers or presentations.

Australian Diabetes Society

For all enquiries:

145 Macquarie Street,
Sydney, NSW, 2000

p: 61 2 9169 3859
e: admin@diabetessociety.com.au

Divisions

Acknowledgement of Country
The Australian Diabetes Society acknowledges the Traditional Custodians of the lands upon which we live, learn and work.
We pay our respects to Elders both past, present and future.

Design by Aptly